DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Private Equity
Paris
Keensight Capital is a European Growth Buyout investor with deep expertise in Technology and Healthcare.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| Keensight Unither Co-Investissement | 2024 | Unknown | Private Equity Fund | n/a | $105M | 0 |
| Keensight Nomios Co-Investment Slp | 2024 | Unknown | Private Equity Fund | n/a | $341M | 0 |
| Keensight Nova VI B | 2024 | Unknown | Private Equity Fund | n/a | $192M | 0 |
| Keensight Pixid Continuation Slp | 2023 | Early deployment | Private Equity Fund | n/a | $42.4M | 0 |
| Keensight Nova VI a | 2023 | Early deployment | Private Equity Fund | n/a | $1.1B | 0 |
| Keensight Spark I | 2022 | Early deployment | Private Equity Fund | n/a | $309M | 0 |
| Keensight Adista Co-Invest Slp | 2022 | Early deployment | Private Equity Fund | n/a | $183M | 0 |
| Keensight Symeres Co-Invest | 2022 | Unknown | Private Equity Fund | n/a | $195M | 0 |
| Keensight V Slp | n/a | Successor fundraising | Private Equity Fund | n/a | $1.5B | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| NovaBone Products LLC | FL | Add on | control | Aug 4, 2026 | n/a | active |
| Pharmanoid | n/a | Add on | control | Dec 18, 2025 | n/a | active |
| DGr Pharma | n/a | Add on | control | Sep 10, 2025 | n/a | active |
| theMatchBox | n/a | Add on | control | Dec 12, 2024 | n/a | active |
| Contegix | n/a | Add on | control | Jul 31, 2024 | n/a | active |
| VectorVMS | Nc | Add on | control | Jun 26, 2024 | n/a | active |
| SoftCo | n/a | platform | control | Mar 5, 2024 | n/a | active |
| Plat4mation | n/a | unknown | unknown | Feb 6, 2024 | n/a | active |
| EcoMundo | n/a | Add on | control | Oct 9, 2023 | n/a | active |
| Regeldienst | n/a | Add on | control | Oct 2, 2023 | n/a | active |
| Attestations | n/a | minority | minority | Jul 25, 2023 | n/a | active |
| CuraTec | n/a | Add on | control | Jul 12, 2023 | n/a | active |
| Nomios | n/a | platform | control | Jun 27, 2023 | n/a | active |
| Oncolines | n/a | Add on | control | Jan 10, 2023 | n/a | active |
| Quanos | n/a | platform | control | Dec 20, 2022 | n/a | active |
| Exemplify BioPharma | n/a | Add on | control | Oct 25, 2022 | n/a | active |
| Bedford Consulting | n/a | platform | control | May 10, 2022 | n/a | active |
| Organix Inc. | n/a | Add on | control | Apr 26, 2022 | n/a | active |
| Buckaroo | n/a | platform | control | Dec 6, 2021 | n/a | active |
| Symeres | n/a | platform | control | May 25, 2021 | n/a | active |
| Connecting-Expertise | n/a | Add on | control | Dec 10, 2020 | n/a | active |
| Carerix | n/a | Add on | control | Apr 19, 2018 | n/a | active |
| Amris ATS | n/a | Add on | control | Mar 9, 2017 | n/a | active |
| Zao | n/a | Add on | control | Mar 9, 2017 | n/a | active |
| Bedfont Scientific | n/a | unknown | unknown | n/a | n/a | active |
| Decision Focus | n/a | unknown | unknown | n/a | n/a | active |
| Uve | n/a | unknown | unknown | n/a | n/a | active |
| Dimo Maint | n/a | unknown | unknown | n/a | n/a | active |
| Actico | n/a | unknown | unknown | n/a | n/a | active |
| MetaCompliance | n/a | unknown | unknown | n/a | n/a | active |
Also named here, with no published line of their own (reach them through the firm): Philippe Crochet (Managing Partner).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan